XCOPRI
Identification of Xcopri
| No description |
Google image searchProduct monograph
Active ingredient
cenobamate, 12.5 MG
DIN: 02538652
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ENDO OPERATIONS LTD.
Date: 20-NOV-2023
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX25 — CENOBAMATE (ATC/DDD)
